Brazilian version of the Addenbrooke Cognitive Examination-revised in the diagnosis of mild Alzheimer disease

Cogn Behav Neurol. 2010 Mar;23(1):8-13. doi: 10.1097/WNN.0b013e3181c5e2e5.

Abstract

Objective: To investigate the accuracy of the Brazilian version of the Addenbrooke Cognitive Examination-revised (ACE-R) in the diagnosis of mild Alzheimer disease (AD).

Background: The ACE-R is an accurate and brief cognitive battery for the detection of mild dementia, especially for the discrimination between AD and frontotemporal dementia.

Methods: The battery was administered to 31 patients with mild AD and 62 age-matched and education-matched cognitively healthy controls. Both groups were selected using the Dementia Rating Scale and were submitted to the ACE-R. Depression was ruled out in both groups by the Cornell Scale for Depression in Dementia. The performance of patients and controls in the ACE-R was compared and receiver operator characteristic curve analysis was undertaken to ascertain the accuracy of the instrument for the diagnosis of mild AD.

Results: The mean scores at the ACE-R were 63.10+/-10.22 points for patients with AD and 83.63+/-7.90 points for controls. The cut-off score <78 yielded high diagnostic accuracy (receiver operator characteristic area under the curve=0.947), with 100% sensitivity, 82.26% specificity, 73.8% positive predictive value, and 100% negative predictive value.

Conclusions: The Brazilian version of the ACE-R displayed high diagnostic accuracy for the identification of mild AD in the studied sample.

MeSH terms

  • Aged
  • Alzheimer Disease / diagnosis*
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / physiopathology
  • Brain / physiopathology
  • Brazil / epidemiology
  • Cognition Disorders / diagnosis*
  • Cognition Disorders / epidemiology
  • Cognition Disorders / physiopathology
  • Female
  • Humans
  • Male
  • Neuropsychological Tests*
  • Sensitivity and Specificity
  • Severity of Illness Index